Search clinical trials for: Cyclophosphamide Doxorrubicin
Total 4613 results
-
Children's Cancer and Leukaemia GroupUnknown
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Cardiac ToxicityUnited States
-
NYU Langone HealthNational Cancer Institute (NCI)Completed
-
UMC UtrechtCenter for Translational Molecular Medicine; Dutch Cancer Society; Vrienden UMC...RecruitingBreast Cancer | Breast Neoplasms | Metastatic Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Invasive Ductal Breast Cancer | Invasive Ductal Carcinoma of Female Breast | Adenocarcinoma BreastNetherlands
-
Peking University People's HospitalRecruiting
-
Priv.-Doz. Dr. med. Joachim RomCompletedEpithelial Ovarian CancerGermany
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI); United States Department of DefenseCompleted
-
Sohag UniversityActive, not recruiting
-
AEterna ZentarisCompletedEndometrial CancerUnited States, Spain, Canada, Ireland, Norway, Austria, Denmark, Israel, United Kingdom, Belgium, Finland, Romania, Czechia, Italy, Poland, Germany, Netherlands, Belarus, Bosnia and Herzegovina, Bulgaria, Russian Federation, Ukraine
-
OncotherapeuticsTakedaCompletedMultiple MyelomaUnited States
-
The Netherlands Cancer InstituteActive, not recruitingBreast CancerNetherlands
-
NSABP Foundation IncGenentech, Inc.; US Oncology ResearchCompleted
-
Duke UniversityGlaxoSmithKlineCompletedLymphoma, B-CellUnited States
-
National Health Research Institutes, TaiwanNational Taiwan University Hospital; Mackay Memorial Hospital; Taipei Veterans... and other collaboratorsCompletedNon-Hodgkin's LymphomaTaiwan
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingStage IIIA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Breast AdenocarcinomaUnited States, Canada
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); The Emmes Company, LLCCompleted
-
Memorial Sloan Kettering Cancer CenterBristol-Myers Squibb; National Cancer Institute (NCI); Genentech, Inc.Completed
-
Leukemia Research FundMedical Research CouncilCompletedLeukemiaUnited Kingdom, Italy, New Zealand, Ireland, Croatia, Russian Federation, Greece, Argentina
-
Societe Internationale d'Oncologie PediatriqueChildren's Cancer and Leukaemia Group; Societe Francaise Oncologie PediatriqueCompletedSarcoma | Small Intestine Cancer | Ovarian CancerFrance, United Kingdom, Ireland
-
Scottish Cancer Therapy NetworkUnknown
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Recurrent NeuroblastomaUnited States
-
University Hospital MuensterMedical Research CouncilUnknown
-
French Innovative Leukemia OrganisationUnknown
-
National Cancer Institute (NCI)Completed
-
Indiana UniversityPfizerCompletedBreast CancerUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Genentech... and other collaboratorsCompletedBreast CancerUnited States
-
OnxeoCompletedCarcinoma, HepatocellularItaly, Spain, United States, Belgium, Austria, France, Egypt, Germany, Hungary, Turkey, Lebanon
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruiting
-
European Organisation for Research and Treatment...NCIC Clinical Trials Group; Nordic Lymphoma Group; Lymphoma Trials Office; Australasian... and other collaboratorsCompletedLymphomaFrance, Netherlands, Spain, Canada, Belgium, Australia, Sweden, United Kingdom, New Zealand, Hungary, Croatia, Czechia, Poland
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); Cancer and Leukemia Group B; North Central Cancer... and other collaboratorsCompleted
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedLymphoma | Nonneoplastic ConditionUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedBreast Cancer | Cardiac ToxicityUnited States
-
Institut BergoniéNational Cancer Institute, FranceCompleted
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Unknown
-
Cancer Research Campaign Clinical Trials CentreCompleted
-
Children's Cancer and Leukaemia GroupUnknown
-
National Cancer Institute (NCI)CompletedBreast CancerUnited States, South Africa
-
Yale UniversityCompletedBreast CancerUnited States
-
Falo, Louis, MDActive, not recruitingCutaneous T Cell LymphomaUnited States
-
Acrotech Biopharma Inc.RecruitingPeripheral T Cell LymphomaUnited States
-
Dana-Farber Cancer InstituteEisai Inc.Active, not recruitingInflammatory Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
Harold J. Burstein, MD, PhDBristol-Myers Squibb; Massachusetts General Hospital; Dana-Farber Cancer Institute and other collaboratorsCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Completed
-
Yale UniversityCompleted
-
Wenqi JiangUnknownR-CHOP Versus R-CDOP as First-line Treatment for Elderly Patients With Diffuse Large-B-cell LymphomaLymphoma, Large B-Cell, DiffuseChina
-
The Netherlands Cancer InstituteBristol-Myers SquibbActive, not recruitingBreast CancerNetherlands
-
Eli Lilly and CompanyCompleted